Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04588389 · ClinicalTrials.gov registry record · Phase 3

Comparison of Quadratus Lumborum Block Types

A Phase 3 study, sponsored by University of Massachusetts, Worcester.

Terminated
Registry status
Phase 3
Development phase
9
Enrollment target

NCT04588389 is a Phase 3 study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04588389, a Phase 3 study, was terminated before completion, sponsored by University of Massachusetts, Worcester.

TERMINATED
Registry status
Phase 3
Development phase
9 participants
Enrollment target

Study Summary

This study will compare the quality of analgesia and reduction of opioid use, between standard of care and two groups of local anesthetic blocks in different location in the quadratus lumborum plane, for postoperative pain control after lumbar spinal fusion and if it reduces opioid consumption.

Interventions

  • DRUG Ropivacaine injection Location 1
  • DRUG Ropivacaine injection Location 2
  • DRUG Multimodal Pharmacological Management

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2020-12-01
Est. Completion 2021-05-14
Phase Phase 3

What the Registry Record Tells You About NCT04588389

The ClinicalTrials.gov registry entry for NCT04588389 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Ropivacaine injection Location 1 is the first listed.

NCT04588389 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04588389 about?

NCT04588389 is a clinical study titled "Comparison of Quadratus Lumborum Block Types". This study will compare the quality of analgesia and reduction of opioid use, between standard of care and two groups of local anesthetic blocks in different location in the quadratus lumborum plane, for postoperative pain control after lumbar spinal fusion and if it reduces opioid consumption.

What is the current status of trial NCT04588389?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2020-12-01. Estimated completion is 2021-05-14.

What interventions are being tested in trial NCT04588389?

The interventions under investigation include: Ropivacaine injection Location 1 (DRUG), Ropivacaine injection Location 2 (DRUG), Multimodal Pharmacological Management (DRUG).

Who is sponsoring clinical trial NCT04588389?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.